Blood online
Home About Blood Authors Subscriptions Permission Advertising Public Access contact us
 

 
Advanced
Current Issue
First Edition
Future Articles
Archives
Submit to Blood
Search
American Society of Hematology
Meeting Abstracts
Email Alerts

Blood, Vol. 111, Issue 8, 4209-4219, April 15, 2008
This Article
Right arrow Abstract
Right arrow Full Text
Services
Right arrow Email this article to a friend
Right arrow Alert me to new issues of the journal
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef

Altered intracellular and extracellular signaling leads to impaired T-cell functions in ADA-SCID patients
Blood Cassani et al. 111: 4209

Supplemental material for: Cassani et al

Files in this Data Supplement:

  • Document 1. Supplementary material and methods (PDF, 22.6 KB)

  • Figure S1. Restored ADA and SAHH activity in T cells from ADA-SCID patients after gene therapy (PDF, 22.6 KB) -
    (A) ADA protein expression detected by intracellular staining in bulk T-cell lines established from ADA-SCID patients, before (ADA-/-, black line) and after HSC gene therapy (GT, grey line), and from healthy controls (ND). The analysis was performed in T cells cultured in FBS-free medium, to avoid the potential interference of bovine ADA in the determination. M.F.I. values are indicated in the histogram plots. (B) ADA and (C) SAHH activity were measured in T cells from five patients and ND (n≥5). The square symbol indicates Pt5.

  • Figure S2. Reduced IkBα phosphorylation in ADA-deficient T cells (PDF, 53 KB) -
    Anti-phospho-IkB immunoblots of CD4+ T cells stimulated with cross-linked (1 µg/ml) anti-CD3 plus (10 µg/ml) anti-CD28 mAbs for the indicated time points. Filters were stripped and re-probed with anti-G3PDH. Upper panel: two patients (ADA-/- and GT) and two ND. Lower panel: cumulative data of densitometric and statistical analysis (* p<0.05) from four patients (ADA-/- and GT) and four ND are presented. Values corresponding to unstimulated cells were subtracted.

  • Figure S3. Analysis of TCR-elicited Ca2+ flux in CD4+ T-cell lines (PDF, 23.7 KB) -
    Ca2+ flux in CD4+ T-cell lines from five ADA-SCID patients and five healthy controls measured by Fluo3-AM dye. FACS analysis of Ca2+ flux was performed after stimulation with cross-linked anti-CD3 mAb. Levels of fluorescence were recorder for 400 ms ca., then ionomycin was added. Representative dot plots from Pt4 (ADA-/- and GT) and one healthy control are shown. Analysis of the MFI calculated at the peak and after 400 ms of stimulation is shown for CD4+ T cells of five patients and five healthy controls in one out two independent determinations.

  • Figure S4. Expression of A2A adenosine receptor in T-cell lines (PDF, 53.7 KB) -
    (A) Expression of A2A adenosine receptor in gated CD4+ T cells. Intracytoplasmic staining was performed in resting cells and M.F.I. values were indicated in the histogram plots. (B) Levels of A2A R mRNA in CD4+ T cells from patients and healthy controls. Total RNA was isolated from either resting or stimulated (1µg/ml antiCD3 plus 10 µg/ml antiCD28) cells and adenosine receptor gene expression was measured by quantitative RT-PCR using the standard curve of a reference sample. Values were measured in duplicates, and normalized by the expression of the housekeeping gene HPRT.





This Article
Right arrow Abstract
Right arrow Full Text
Services
Right arrow Email this article to a friend
Right arrow Alert me to new issues of the journal
Right arrow reprints & permissions
Right arrow Rights and Permissions
Citing Articles
Right arrow Citing Articles via CrossRef

 click for free articles
home about blood authors subscriptions permissions advertising public access contact us
  Copyright © 2009 by American Society of Hematology         Online ISSN: 1528-0020